Dr. Oleksandr Ivanovych Kovalchuk, MD

Dr. Kovalchuk practices at Silver Springs Shores Dialysis in Ocala, Florida.

Dr. Kovalchuk's NPI, 1437390788, was assigned on March 17, 2009. Dr. Kovalchuk graduated from Vinnica State Medical University in 2001. Dr. Kovalchuk holds Florida license ME103932.

Dr. Kovalchuk's primary practice is Silver Springs Shores Dialysis, at 2980 SE 3rd Ct, Ocala, FL 34471 in Marion County. The practice phone is (352) 687-0403.

Dr. Kovalchuk's primary practice is Silver Springs Shores Dialysis in Ocala, Florida. Dr. Kovalchuk is also affiliated with HCA Florida Ocala Hospital. The medical group on file is Ocala Kidney Group. Dmand AI also links Dr. Kovalchuk to 2 more hospitals, 5 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kovalchuk practices, 9 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Kovalchuk's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Kovalchuk is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Kovalchuk's licenses on file in 2 states: Florida and Connecticut.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances and kidney disease among the conditions Dr. Kovalchuk treats.

CMS data shows 2,267 Medicare services from Dr. Kovalchuk across 12 procedure codes in 2024, for 425 Medicare patients. Medicare paid $211,594 for them.

CMS counts 425 Medicare patients who saw Dr. Kovalchuk in 2024. The largest group is 75 to 84, with 163 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 20% are also on Medicaid. Their average risk score is 3.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kovalchuk's median patient age at 75, with 47% women.

In 2024, Dr. Kovalchuk wrote 1,281 Medicare Part D claims for 191 patients. 88% of them were for generic drugs. CMS names the drug for 1,023 of them, across 28 drugs with 11 or more claims each, at $70,257 in total drug cost. In 2023, CMS named 947 claims across 27 drugs.

Dr. Kovalchuk accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 20 papers to Dr. Kovalchuk, published from 2018 to 2025. 2023 was the busiest year, with 5. The most frequent topics are Rats, Wistar, Endothelial Cells and Hypertension. Dr. Kovalchuk has published most often in Wiad Lek. Dr. Kovalchuk's most frequent co-author is Kateryna Strubchevska.

CMS Open Payments shows 169 general payments to Dr. Kovalchuk from 26 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $703.

Dmand AI lists 1 award for Dr. Kovalchuk, most recently CMS Stage 1 EHR in 2013.

Dr. Kovalchuk graduated from Vinnica State Medical University in 2001.

Dr. Kovalchuk is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.